ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
MDS has agreed to pay $615 million in cash to acquire Molecular Devices, a Sunnyvale, Calif.-based provider of instrumentation for screening, cellular analysis, and biochemical testing. Based in Canada, MDS has businesses in pharmaceutical contract research, medical isotopes, radiotherapeutics, and analytical instruments. After the acquisition, it intends to merge Molecular Devices with its MDS Sciex mass spectrometry unit. The combined life sciences research products and instrumentation business will have more than 1,100 employees, including about 250 scientists and engineers. For the 12 months ending Sept. 30, 2006, Molecular Devices had revenues of $185 million.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter